FIELD: medicine, infectology.
SUBSTANCE: in erysipelas-suffering patients during the first 3 d of the disease mentioned one should sample venous blood for biochemical testing the values of oxidant-antioxidant system and detecting the content of lipid hydroperoxides and superoxide dismutase (SOD) in plasma, in serum - total peroxidase activity (TPA), concentration of malonic dialdehyde (MDA) and activity of catalase (C), then one should calculate the value for oxidant-antioxidant coefficient (OAC) by the following formula: 
where 
- the values of tested biochemical values in patients, and 
- those in healthy people. At OAC value being 2.1 U and more one should predict favorable effect due to emoxypin-therapy.
EFFECT: higher efficiency.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING EARLY ERYSIPELAS RECURRENCE CASES | 1999 |
|
RU2144191C1 |
| METHOD FOR PREDICTING BULLOUS AND HEMORRHAGIC FORMS OF ERYSIPELAS | 1999 |
|
RU2148258C1 |
| METHOD OF DETERMINING INDICATIONS FOR ADMINISTERING EMOXIPIN IN TREATMENT OF TOXIC DIPHTHERIA | 1998 |
|
RU2137128C1 |
| METHOD FOR DETERMINING TOXIC DIPHTHERIA DEVELOPMENT COURSE | 1997 |
|
RU2135998C1 |
| METHOD FOR PREDICTION OF HEMORRHAGIC FORMS OF DISEASE DEVELOPING IN PATIENTS, SUFFERING FROM ERYSIPELAS OF LOWER EXTREMITIES | 2015 |
|
RU2601370C1 |
| RECURRENT ERYSIPELAS PREVENTION METHOD | 2007 |
|
RU2354144C1 |
| METHOD OF TREATMENT OF PATIENTS WITH ERYSIPELAS | 1995 |
|
RU2120286C1 |
| METHOD FOR PREDICTING CHRONIC RELAPSING DISEASE COURSE IN PERSONS RECOVERED FROM PRIMARY ERYSIPELAS | 1995 |
|
RU2101701C1 |
| METHOD OF ERYSIPELAS RECIDIVATION PREDICTION | 2006 |
|
RU2332847C2 |
| METHOD OF TREATING ERYSIPELAS | 2012 |
|
RU2502530C1 |
